Markerstudy "keen to get back on the acquisition drug" after £200m investment
Markerstudy is hoping to make an acquisition in the UK in the first quarter of this year, according to group underwriting director Gary Humphreys.
It was revealed earlier this week that the provider had secured a £200m investment deal led by Pollen Street Capital.
Humphreys told Insurance Age that the managing general agent had been looking for external investment for some time, adding “we’d got to the stage where the group was of such a size that running it from personal funding was limiting
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected].
You are currently unable to print this content. Please contact [email protected] to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
More on Insurer
Videos/Podcasts
Insurance Covid-Cast: How has staff productivity been impacted by remote working?
For the 35th episode of Post and Insurance Age’s video series we gathered together a panel of senior insurance managers to discuss how productive staff have been since Covid-19 lockdown, and whether it has changed as restrictions have eased?
Subscribe to our daily newsletter for all the latest news
Most read
- Aviva’s Covid-19 BI claims exposure down to broker wordings
- Masojada: Hiscox regrets "anguish and uncertainty" caused by Covid-19 BI dispute
- Aston Lark snaps up Scottish broker
- Aviva to buy Axa XL's Private Clients business
- Interview: Ecclesiastical's Richard Coleman
- Aston Lark buys Magenta Insurance
- Inflexion reveals fresh broker investment following Bollington sale